Malaysia
Search
Sign In
Ophthalmology
Top Medical News
Supplementation with lutein/zeaxanthin instead of beta carotene is safe and does not contribute to an increase in lung cancer risk while having a potential beneficial effect on the risk of progression to late age-related macular degeneration (AMD), according to data from the Age-Related Eye Disease Study 2 (AREDS2) study.
Macular retinal nerve fibre layer (RNFL) thickness appears to be a useful prognostic biomarker of long-term cognitive decline in older adults, a study from Korea has found.
Adjuvant therapy with 5-fluorouracil (5-FU) and low molecular weight heparin in high-risk patients with rhegmatogenous retinal detachment (RRD) does not help prevent the development of proliferative vitreoretinopathy, as shown in a study.
In clinical practice, patients with neovascular age-related macular degeneration (nAMD), diabetic macular oedema (DMO), and retinal vein occlusion (RVO) see treatment outcomes that are inferior to those reported in pivotal phase 3 studies, according to a recent study.
Individuals who present with reticular pseudodrusen (RPD) are at high risk of progression to late age-related macular degeneration (AMD), with the risk increase varying by RPD severity, as shown in a post hoc analysis of two clinical trials. The risk of progression is high at low-to-moderate RPD levels and low at high RPD levels.
Patients with conjunctival melanoma exhibit a high frequency of BRAF and NRAS mutations, as well as ATRX and NF1 mutations, reports a study.
Children with vision impairment often experience greater symptoms of depression and anxiety, according to a recent study. Surgical treatment helps improve these mental health symptoms.
Special Reports
A new algorithm objectively determines when intraocular lens implant (IOL) surgery should be performed, regardless of how the opacity looks to the surgeon.
Bilastine 10 mg orodispersible tablet
Roxadustat treatment for anaemia in patients with dialysis-dependent chronic kidney disease (DD CKD) does not come with an increased risk of ophthalmic abnormalities, according to a phase III trial conducted in Japan.
